Insulin secretion: Function and therapy of pancreatic beta-cells in diabetes

British Journal of Diabetes and Vascular Disease

Volumn 5, Issue 4, 2005, Pages 187-191

  Rorsman, Patrik ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Beta cell; Insulin resistance; Insulin secretion; Type 2 diabetes

Indexed keywords

ANTIDIABETIC AGENT; INSULIN; SULFONYLUREA;

AGE; CELL FUNCTION; DIABETES MELLITUS; DRUG MECHANISM; GENETIC PREDISPOSITION; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RELEASE; METABOLIC REGULATION; OBESITY; PANCREAS ISLET; PANCREAS ISLET BETA CELL; REVIEW; SIGNAL TRANSDUCTION;

EID: 24944478087     PISSN: 14746514     EISSN: None     Source Type: Journal    
DOI: 10.1177/14746514050050040201     Document Type: Review

References (49)

1. Olofsson CS, Gopel SO, Barg S et al. Fast insulin secretion reflects exocytosis of docked granules in mouse pancreatic B-cells. Pflugers Arch 2002;444:43-51.
2. Jansson L, Hellerstrom C. Stimulation by glucose of the blood flow to the pancreatic islets of the rat. Diabetologia 1983; 25:45-50.
3. Michael MD, Kulkarni RN, Postic C et al. Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol Cell 2000;6(1):87-97.
4. Ashcroft FM, Rorsman P. Electrophysiology of the pancreatic beta-cell. Prog Biophys Mol Biol 1989;54(2):87-143.
5. Ashcroft FM, Proks P, Smith PA, Ammala C, Bokvist K, Rorsman P. Stimulus-secretion coupling in pancreatic beta cells. J Cell Biochem 1994; 55(suppl):54-65.
6. Henquin JC, Meissner HP. Significance of ionic fluxes and changes in membrane potential for stimulus-secretion coupling in pancreatic B-cells. Experientia 1984;40:1043-52.
7. Schulla V, Renstrom E, Feil R et al., editors. Impaired insulin secretion and glucose tolerance in beta cell-selective Ca(v)1.2 Ca2+ channel null mice. EMBO J 2003;22:3844-54.
8. Seino S. ATP-sensitive potassium channels: a model of heteromultimeric potassium channel/receptor assemblies. Annu Rev Physiol 1999;61:337-62.
9. Babenko AP, Aguilar-Bryan L, Bryan J. A view of sur/KIR6.X, KATP channels. Annu Rev Physiol 1998;60:667-87.
10. Gribble FM, Ashcroft FM. Sulfonylurea sensitivity of adenosine triphosphate-sensitive potassium channels from beta cells and extrapancreatic tissues. Metabolism 2000;49(10 suppl 2):3-6.
11. Henquin JC. Triggering and amplifying pathways of regulation of insulin secretion by glucose. Diabetes 2000;49:1751-60.
12. Kane C, Shepherd RM, Squires PE et al. Loss of functional KATP channels in pancreatic beta-cells causes persistent hyperinsulinemic hypoglycemia of infancy. Nat Med 1996; 2:1344-7.
13. Rorsman P. Renstrom E. Insulin granule dynamics in pancreatic beta cells. Diabetologia 2003;46:1029-45.
14. Hosker JP, Rudenski AS, Burnett MA, Matthews DR, Turner RC. Similar reduction of first- and second-phase B-cell responses at three different glucose levels in type II diabetes and the effect of gliclazide therapy. Metabolism 1989;38:767-72.
15. Kashyap S, Belfort R, Gastaldelli A et al. A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes. Diabetes 2003;52:2461-74.
16. Neher E. Vesicle pools and Ca2+ microdomains: new tools for understanding their roles in neurotransmitter release. Neuron 1998;20:389-99.
17. Bratanova-Tochkova TK, Cheng H, Daniel S et al. Triggering and augmentation mechanisms, granule pools, and biphasic insulin secretion. Diabetes 2002;51(suppl 1):583-S90.
18. Stumvoll M, Gerich J. Clinical features of insulin resistance and beta cell dysfunction and the relationship to type 2 diabetes. Clin Lab Med 2001;21(1):31-51.
19. Kahn SE. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes. Diabetologia 2003;46(1):3-19.
20. Gerich JE. Is insulin resistance the principal cause of type 2 diabetes? Diabetes Obes Metab 1999;1:257-63.
21. Rahier J, Goebbels RM, Henquin JC. Cellular composition of the human diabetic pancreas. Diabetologia 1983;24:366-71.
22. Ashcroft F, Rorsman P. Type 2 diabetes mellitus: not quite exciting enough? Hum Mol Genet 2004;13:R21-R31.
23. Ashcroft FM, Rorsman P. Molecular defects in insulin secretion in type-2 diabetes. Rev Endocr Metab Disord 2004; 5:135-42.
24. Yaney GC, Corkey BE. Fatty acid metabolism and insulin secretion in pancreatic beta cells. Diabetologia 2003; 46:1297-312.
25. Weir GC, Bonner-Weir S. Five stages of evolving beta-cell dysfunction during progression to diabetes. Diabetes 2004; 53(suppl 3):S16-S21.
26. Krauss S, Zhang CY, Scorrano L et al. Superoxide-mediated activation of uncoupling protein 2 causes pancreatic beta cell dysfunction. J Clin Invest 2003;112:1831-42.
27. Zhang CY, Baffy G, Perret P et al. Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, beta cell dysfunction, and type 2 diabetes. Cell 2001; 105:745-55.
28. Fava D, Cassone-Faldetta M, Laurenti O, De Luca O, Ghiselli A, De Mattia G. Gliclazide improves anti-oxidant status and nitric oxide-mediated vasodilation in Type 2 diabetes. Diabet Med 2002; 19:752-7.
29. Maestre I, Jordan J, Calvo S et al. Mitochondrial dysfunction is involved in apoptosis induced by serum withdrawal and fatty acids in the beta-cell line INS-1. Endocrinology 2003; 144:335-45.
30. Koshkin V, Wang X, Scherer PE, Chan CB, Wheeler MB. Mitochondrial functional state in clonal pancreatic beta-cells exposed to free fatty acids. J Biol Chem 2003;278:19709-15.
31. Moore PC, Ugas MA, Hagman DK, Parazzoli SD, Poitout V. Evidence against the involvement of oxidative stress in fatty acid inhibition of insulin secretion. Diabetes 2004;53:2610-16.
32. Chan CB, De Leo D, Joseph JW et al. Increased uncoupling protein-2 levels in beta-cells are associated with impaired glucose-stimulated insulin secretion: mechanism of action. Diabetes 2001;50:1302-10.
33. Joseph JW, Koshkin V, Saleh MC et al. Free fatty acid-induced beta-cell defects are dependent on uncoupling protein 2 expression. J Biol Chem 2004;279:51049-56.
34. Petersen KE, Befroy D, Dufour S et al. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 2003;300:1140-2.
35. Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 2004; 350:664-71.
36. Trifunovic A, Wredenberg A, Falkenberg M et al. Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature 2004;429:417-23.
37. Tsuura Y, Ishida H, Okamoto Y et al. Glucose sensitivity of ATP-sensitive K+ channels is impaired in beta-cells of the GK rat. A new genetic model of NIDDM. Diabetes 1993; 42:1446-53.
38. Smith PA, Rorsman P, Ashcroft FM. Modulation of dihydropyridine-sensitive Ca2+ channels by glucose metabolism in mouse pancreatic beta-cells. Nature 1989;342:550-3.
39. Barg S, Huang P, Eliasson et al. Priming of insulin granules for exocytosis by granular Cl(-) uptake and acidification. J Cell Sci 2001;114:2145-54.
40. Barg S, Eliasson L, Renstrom E, Rorsman P. A subset of 50 secretory granules in close contact with L-type Ca2+ channels accounts for first-phase insulin secretion in mouse beta-cells. Diabetes 2002;51(suppl 1):S74-S82.
41. Olsen HL, Hoy M, Zhang W et al. Phosphatidylinositol 4-kinase serves as a metabolic sensor and regulates priming of secretory granules in pancreatic beta cells. Proc Natl Acad Sci USA 2003; 100:5187-92.
42. Gromada J, Holst JJ, Rorsman P. Cellular regulation of islet hormone secretion by the incretin hormone glucagon-like peptide 1. Pflugers Arch 1998;435:583-94.
43. Ball AJ, McCluskey JT, Flatt PR, McClenaghan NH. Drug-induced desensitization of insulinotropic actions of sulfonylureas. Biochem Biophys Res Comm 2000;271:234-9.
44. Charpentier G. Oral combination therapy for type 2 diabetes. Diabetes Metab Res Rev 2002;18(suppl 3):S70-S76.
45. Trube G, Rorsman P, Ohno-Shosaku T. Opposite effects of tolbutamide and diazoxide on the ATP-dependent K+ channel in mouse pancreatic beta-cells. Pflugers Arch 1986;407:493-9.
46. Eliasson L, Renstrom E, Ammala C et al. PKC-dependent stimulation of exocytosis by sulfonylureas in pancreatic beta cells. Science 1996;271:813-15.
47. Fuhlendorff J, Rorsman P, Kofod H et al. Stimulation of insulin release by repaglinide and glibenclamide involves both common and distinct processes. Diabetes 1998;47:345-51.
48. Efanova IB, Zaitsev SV, Zhivotovsky B et al. Glucose and tolbutamide induce apoptosis in pancreatic beta-cells. A process dependent on intracellular Ca2+ concentration. J Biol Chem 1998; 273:33501-07.
49. Maedler K, Carr RD, Bosco D, Zuellig RA, Berney T, Donath MY. Sulphonylurea induced {beta}-cell apoptosis in cultured human islets. J Clin Endocrinol Metab 2005;90:501-06.